Join Us to Discover What's Next

Gilead employees

Search Open Positions

Be part of Gilead’s journey as we strive to solve some of the world’s biggest healthcare challenges.

Working at Gilead

Gilead has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a better, healthier world for all people. We have commercialized more than 25 innovative medicines, helping to transform treatment for people living with HIV, viral hepatitis, cancer and other life-threatening diseases. Through our ongoing bold and transformative science, we’re driving innovations that have the potential to become the next generation of life-changing medicines.

Our employees include some of the most talented innovators in the biopharmaceutical industry. We are always looking for the next wave of passionate people interested in joining an intellectually stimulating, socially responsible company with a track record of addressing serious illnesses and public health issues around the world. Every member of our team plays a critical and visible role in helping to discover, develop and deliver innovative therapeutics for people with life-threatening diseases. Because the impossible is not impossible. It’s what’s next.

A Look Inside the Innovation

Have you ever been curious about what goes into making innovative new medicines? In the latest episode of our “Inside the Innovation” series, learn about Gilead’s patient-first approach to pharmaceutical manufacturing from Monica Tijerina, Vice President, External Manufacturing, Clinical Supply Chain and Logistics, and Ken Kent, Senior Vice President of Chemical Development and Manufacturing. Listen in as Monica and Ken discuss what motivates them, share career highlights, and reflect on the critical role of inclusion and diversity in their work.

View Transcript
CREW:
Okay, B camera. Here we go. Set and action.

KEN:
Hey Monica.

MONICA:
Hey Ken.

KEN:
Good to see you. 

MONICA:
Good to see you! How should we start?

KEN:
Hi, my name’s Ken Kent, and I'm the Senior Vice President of Chemical Development and Manufacturing here at Gilead Sciences.

MONICA:
Hi, my name is Monica Tijerina. I'm in Global Supply Chain and External Manufacturing within Pharmaceutical Development and Manufacturing. 

Our industry uses many acronyms. So PDM, what does PDM stand for within Gilead and what does PDM do?

KEN:
Yeah, that's a good question. You know, PDM stands for Pharmaceutical Development and Manufacturing. So pharmaceutical development is really: How do you make it? How do you test it? How do you administer it? So, when a compound first comes out of research, whether a small molecule or biologic, it's really an idea. And that will have to be tested—is it safe and effective in people? There's so much to figure out and really, we want it to be the optimal patient experience really, so what would be best for patients and how do we deliver that? 

You know, the sort of, team dynamics are really integral to what we do. Can you give me a sense of how your team operates, and who do you work with and for?

MONICA:
In discovery, it's really important that we're there with the scientists that are identifying targets to treat HIV or treat a type of cancer. And so, you would have direct interaction with many individuals within research. And then as you start to progress into developing commercial, it opens up who you're working with as far as understanding what the patient needs are, making sure you develop the best medicine possible for them. 

Many people go to the pharmaceutical industry because they have a personal connection. Do you have a personal connection? What drove you to join Gilead?

KEN:
Well, you know, when I first interviewed at Gilead, I thought it was really exciting the passion that the founder had for the company and the belief that we were going to make a difference and have impact on patients’ lives. And right off the bat in the late 80s, we started working on HIV treatments and in the Bay Area, HIV was just a devastating disease. And in fact, I had two brother-in-laws that both passed from HIV. I remember I was at one of our manufacturing sites and we were really pushing to get these compounds to the patients, and I was telling this supplier, I’m going to ask really unreasonable things of you for a very reasonable cause, because this could be your mother, your father, your brother, your sister.

MONICA:
Definitely, I can understand what you're saying.

KEN:
Monica, you know, there's a lot going on at Gilead—that's an understatement. How do you keep your energy up? How do you maintain that same easy demeanor and get-it-done attitude?

MONICA:
If you love science, or you have somebody who’s been impacted by a disease, this is a career that you can choose, and it’s very rewarding, it gives back more than I put in. So, I think for me, I really feel very passionate around STEM education for American students, and we don't produce enough American students that pursue a career in STEM, and so with me, I've been very fortunate to get an opportunity to lead Gileados, that's an employee resource group for Latinos. And so, we spend time to support the Latino community and support STEM education. 

So, Ken, you've been with Gilead a very long time. And I want to ask you in your 33 years at Gilead, what is your most memorable project that you've worked on?

KEN:
Boy, my most memorable project in 33 years at Gilead? That's a good question. I think when we got our first approval for a COVID-19 treatment. To get that done as quickly as the team did, under such unusual circumstances, was just phenomenal. I couldn't be prouder of them. 

Monica, so you know, Gilead’s talked a lot about not only what we do but focusing on how we do it and part of that is really trying to grow through diversity , diversity of thought, and inclusion of all voices. Can you tell a little bit of how that positively impacts our ability to develop new medicines? 

MONICA:
So, there's been a lot of research that shows when you have individuals who think differently, and you have people who will listen to those unique ideas, that you get to a better outcome. And so, development of medicines are no different. Just a diverse set of individuals from years of industry, gender, training, you know, education, all of those give you different perspectives. Without that diverse group, you will naturally just have blind spots, and so listening to those individuals always helps to get to a better outcome.

KEN:
Monica, it's been a lot of fun. Thank you so much for spending time with me.

MONICA:
Thank you, Ken, I really enjoyed our time here together and just thank you for sitting with me today and sharing your stories. Always a pleasure. 

KEN:
Alright, see you soon. Bye.

MONICA:
Bye.

 

Learn More About Who We Are

Gilead employees working
Meet Our Employees

Get to know the talented people who are helping Gilead create a better, healthier world for all people.

Two Gilead employees speaking
Our Commitment to Inclusion and Diversity

We’re growing a diverse workforce to help drive innovation at Gilead.

A scientist in the lab
Advancing Global Health

We’re collaborating with our partners to improve access to care around the world.

Equal Opportunities

As an equal opportunity employer, Gilead Sciences, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job-related characteristics or other prohibited grounds specified in applicable federal, state and local laws. It is also Gilead’s policy to comply with all applicable federal, state and local laws respecting consideration of unemployment status in making hiring decisions. For more information about equal employment opportunity protections, please view the EEO is the Law poster.

Notice: Employee Polygraph Protection Act

Your Rights Under the Family and Medical Leave Act

Pay Transparency Nondiscrimination Provision

To ensure reasonable accommodations are provided to individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance.

A Message from Gilead’s Talent Acquisition Team

We encourage all qualified individuals who are passionate about our mission and want to help make a difference through our work to apply online. Candidates who are selected for further consideration will be contacted by a member of the company’s internal recruiting team.

COVID-19 Updates

Following extensive monitoring, research, consideration of business implications, and advice from internal and external experts, Gilead has made the decision to require all U.S., Canada and Australia employees and contractors to be fully vaccinated against COVID-19 as a condition of employment. The health of our employees, contractors, their loved ones, our partners and the communities and people we serve is a top priority. Vaccination is the most effective way currently available to deliver on that priority.

The purpose of the vaccination requirement is to minimize the spread of COVID-19 in the workplace and support the health and safety of our communities. A person is considered fully vaccinated two weeks after the second dose of a two-dose vaccine or two weeks after a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request an accommodation.